|
Sep 19
|
Achilles Therapeutics Announces Strategic Update
|
|
Jan 24
|
Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year?
|
|
Dec 18
|
Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction
|
|
Nov 13
|
Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
|
|
Aug 10
|
Jazz (JAZZ) Beats on Q2 Earnings & Sales, Raises '23 View
|
|
May 10
|
Achilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
|
|
May 10
|
Achilles Therapeutics’ New Immunogenicity Prediction Application of its AI-Powered PELEUS™ Platform Uniquely Identifies the Most Potent T Cell Antigens
|
|
Apr 25
|
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
|
|
Apr 25
|
Achilles Therapeutics Announces Grant of US Patent Covering the Treatment of Patients with an Immunotherapy Targeting Neoantigens Based on Tumor HLA Status
|
|
Apr 22
|
Is Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Deliver On Growth Plans?
|